An IgG-like fusion protein molecule (VEGF receptor 31-immunoglobulin, VEGFR31-Ig) binding VEGFC has been developed to inhibit lymphangiogenesis, thereby suppressing cancer growth and metastasis.168. The gene discussed is VEGFC; the disease is cancer.